Cargando…
MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
BACKGROUND: Diabetes is a leading cause of mortality and morbidity across the world. Over 50% of deaths among diabetic patients are caused by cardiovascular diseases. Cardiac diastolic dysfunction is one of the key early signs of diabetic cardiomyopathy, which often occurs before systolic dysfunctio...
Autores principales: | Dai, Beibei, Li, Huaping, Fan, Jiahui, Zhao, Yanru, Yin, Zhongwei, Nie, Xiang, Wang, Dao Wen, Chen, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122727/ https://www.ncbi.nlm.nih.gov/pubmed/30180843 http://dx.doi.org/10.1186/s12933-018-0767-z |
Ejemplares similares
-
MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα
por: Yin, Zhongwei, et al.
Publicado: (2019) -
miR-217 Promotes Cardiac Hypertrophy and Dysfunction by Targeting PTEN
por: Nie, Xiang, et al.
Publicado: (2018) -
The Cell Type–Specific Functions of miR-21 in Cardiovascular Diseases
por: Dai, Beibei, et al.
Publicado: (2020) -
miR-320a induces pancreatic β cells dysfunction in diabetes by inhibiting MafF
por: Du, Hengzhi, et al.
Publicado: (2021) -
Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart
por: Li, Huaping, et al.
Publicado: (2019)